L279-0507 Screening compound: N,N,1-trimethyl-2-({methyl[(2-phenylethyl)carbamoyl]amino}methyl)-1H-1,3-benzodiazole-5-carboxamide

L279-0507 Screening compound: N,N,1-trimethyl-2-({methyl[(2-phenylethyl)carbamoyl]amino}methyl)-1H-1,3-benzodiazole-5-carboxamide
L279-0507 Screening compound: N,N,1-trimethyl-2-({methyl[(2-phenylethyl)carbamoyl]amino}methyl)-1H-1,3-benzodiazole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L279-0507
N,N,1-trimethyl-2-({methyl[(2-phenylethyl)carbamoyl]amino}methyl)-1H-1,3-benzodiazole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L279-0507

Molecular Formula

C22H27N5O2 (C22 H27 N5 O2)

Compound Name

N,N,1-trimethyl-2-({methyl[(2-phenylethyl)carbamoyl]amino}methyl)-1H-1,3-benzodiazole-5-carboxamide

IUPAC name

NN1-trimethyl-2-({methyl[(2-phenylethyl)carbamoyl]amino}methyl)-1H-13-benzodiazole-5-carboxamide

SMILES

CN(C)C(c(cc1)cc2c1n(C)c(CN(C)C(NCCc1ccccc1)=O)n2)=O

InChI

InChI=1S/C22H27N5O2/c1-25(2)21(28)17-10-11-19-18(14-17)24-20(27(19)4)15-26(3)22(29)23-13-12-16-8-6-5-7-9-16/h5-11,14H,12-13,15H2,1-4H3,(H,23,29)

InChI Key

OHJCZZIDMHJVRR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27239537

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

393.49

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.447

Distribution Coefficient, logD

1.445

Water Solubility, LogSw

-2.24

Polar Surface Area

54.360

Acid Dissociation Constant (pKa)

15.37

Base Dissociation Constant (pKb)

4.84

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.80

L279-0507 in Drug Discovery

Included in Screening Libraries

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

PI3K-Targeted Library (17255 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases

References: we are preparing a list of scientific research reports with L279-0507 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L279-0507?
Check Price and Availability of L279-0507, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L279-0507 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L279-0507
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L279-0507
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L279-0507 available by request